Rahul A. Sheth, MD

Associate Professor
University of Texas MD Anderson Cancer Center

Presentation(s):

• Role of IO for Melanoma

  Sunday, March 5, 2023
  3:58 PM – 4:04 PM

  Disclosure information not submitted.

• Development and preclinical evaluation of an immunotherapy-eluting microsphere for stimulating tumor immunity in hepatocellular carcinoma

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Quality and Outcome Metrics for Curative-Intent Interventional Oncology Procedures

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Quality and Outcome Metrics for Palliative Interventions in Cancer Patients

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Vertebral Augmentation and Radiofrequency Ablation for the Treatment of Fractures in Cancer Patients

  Monday, March 6, 2023
  3:27 PM – 3:36 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Hepatic Arterial Infusion of the Class C TLR9 Agonist SD-101 in Pressure Enabled Regional Immuno-Oncology (PERIO) Phase 1 Trials for Liver Tumors

  Monday, March 6, 2023
  4:12 PM – 4:21 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Modulating the Tumor Immune Microenvironment with Locoregional Image-Guided Interventions

  Monday, March 6, 2023
  5:30 PM – 5:35 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• The role of the peripheral nervous system on tumor progression: an anatomic investigation

  Tuesday, March 7, 2023
  3:09 PM – 3:18 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Wednesday Closing Plenary Session: Act Local, Think Global: IR and its role in Immuno-oncology and Abstracts of the Year and Best Posters recognition

  Wednesday, March 8, 2023
  10:30 AM – 12:00 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• Development and preclinical evaluation of an immunotherapy-eluting hydrogel platform for stimulating tumor immunity

  Wednesday, March 8, 2023
  10:30 AM – 10:40 AM

  Disclosure information not submitted.

• Q&A: Act Local, Think Global: IR and its role in Immuno-oncology

  Wednesday, March 8, 2023
  12:30 PM – 1:00 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()

• GU Oligometastatic disease treatment

  Wednesday, March 8, 2023
  1:15 PM – 1:30 PM

  Disclosure(s): Boston Scientific: Consultant (), Research Grant or Support (); Medtronic: Consultant (); Replimune: Consultant (Ongoing); Siemens: Consultant (Ongoing); Trisalus: Consultant ()